» Articles » PMID: 36005175

The Effect of Tobacco Smoke -Nitrosamines, NNK and NDEA, and Nicotine, on DNA Mismatch Repair Mechanism and MiRNA Markers, in Hypopharyngeal Squamous Cell Carcinoma: An In Vivo Model and Clinical Evidence

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2022 Aug 25
PMID 36005175
Authors
Affiliations
Soon will be listed here.
Abstract

Deregulation of the DNA mismatch repair (MMR) mechanism has been linked to poor prognosis of upper aerodigestive tract cancers. Our recent in vitro data have provided evidence of crosstalk between deregulated miRNAs and MMR genes, caused by tobacco smoke (TS) -Nitrosamines, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in hypopharyngeal cells. Here, we explored whether chronic exposure to TS components can affect MMR mechanism and miRNA profiles in hypopharyngeal mucosa. Using a mouse model (C57Bl/6J wild type) of in vivo 14-week exposure to NNK (0.2 mmol/L) and -Nitrosodiethylamine (NDEA; 0.004 mmol/L), with or without nicotine (0.02 μmol/L), we provide direct evidence that TS components can promote dysplasia, significant downregulation of and genes and deregulation of miR-21, miR-155, miR-34a, and miR-451a. By analyzing eight human specimens from tobacco smokers and eight controls, we provide clinical evidence of a significant reduction in and mRNAs in hypopharyngeal squamous cell carcinoma (HSCC). In summary, deregulation of the MMR mechanism and miRNAs is caused by chronic exposure to TS-related -Nitrosamines, with or without nicotine, in the early stages of upper aerodigestive tract carcinogenesis, and can also be detected in human HSCC. Thus, we encourage future studies to further elucidate a possible in vivo dose-dependent effect of individual or combined -Nitrosamines, NNK and/or NDEA, and nicotine, on the MMR mechanism and their clinical testing to elaborate prognosis and risk assessment.

Citing Articles

Clinical relationships between the intratumoral microbiome and risk factors for head and neck cancer.

Hamada M, Nishiyama K, Nomura R, Akitomo T, Mitsuhata C, Yura Y Heliyon. 2024; 10(20):e39284.

PMID: 39497974 PMC: 11533578. DOI: 10.1016/j.heliyon.2024.e39284.


Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications.

Vageli D, Doukas P, Goupou K, Benos A, Astara K, Zacharouli K Oncol Res. 2024; 32(8):1239-1256.

PMID: 39055895 PMC: 11267112. DOI: 10.32604/or.2024.052130.


Cell signaling and epigenetic regulation of nicotine-induced carcinogenesis.

Sun Q, Jin C Environ Pollut. 2024; 345:123426.

PMID: 38295934 PMC: 10939829. DOI: 10.1016/j.envpol.2024.123426.


The role of microRNAs in nicotine signaling.

Hajiasgharzadeh K, Naghipour B, Shahabi P, Dastmalchi N, Alipour M EXCLI J. 2023; 22:433-450.

PMID: 37346805 PMC: 10279964. DOI: 10.17179/excli2023-6096.


Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers.

Khan A, Patel R, McDonald M, Goethe E, English C, Gadot R J Neurooncol. 2023; 163(2):397-405.

PMID: 37318677 DOI: 10.1007/s11060-023-04359-7.


References
1.
Gale N, Blagus R, El-Mofty S, Helliwell T, Prasad M, Sandison A . Evaluation of a new grading system for laryngeal squamous intraepithelial lesions--a proposed unified classification. Histopathology. 2014; 65(4):456-64. DOI: 10.1111/his.12427. View

2.
Mao G, Lee S, Ortega J, Gu L, Li G . Modulation of microRNA processing by mismatch repair protein MutLα. Cell Res. 2012; 22(6):973-85. PMC: 3367530. DOI: 10.1038/cr.2012.18. View

3.
Siemens H, Neumann J, Jackstadt R, Mansmann U, Horst D, Kirchner T . Correction: Detection of miR-34a Promoter Methylation in Combination with Elevated Expression of c-Met and β-Catenin Predicts Distant Metastasis of Colon Cancer. Clin Cancer Res. 2022; 28(8):1739. DOI: 10.1158/1078-0432.CCR-22-0505. View

4.
Mohr A, Mott J . Overview of microRNA biology. Semin Liver Dis. 2015; 35(1):3-11. PMC: 4797991. DOI: 10.1055/s-0034-1397344. View

5.
Sanner T, Grimsrud T . Nicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A Review. Front Oncol. 2015; 5:196. PMC: 4553893. DOI: 10.3389/fonc.2015.00196. View